Fideuram Asset Management Ireland dac Invests $5.66 Million in Teleflex Incorporated $TFX

Fideuram Asset Management Ireland dac acquired a new position in shares of Teleflex Incorporated (NYSE:TFX) in the 4th quarter, HoldingsChannel reports. The institutional investor acquired 50,387 shares of the medical technology company’s stock, valued at approximately $5,662,000.

Other institutional investors have also modified their holdings of the company. Banque Cantonale Vaudoise lifted its position in shares of Teleflex by 82.5% during the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after purchasing an additional 113 shares during the last quarter. Hantz Financial Services Inc. lifted its position in shares of Teleflex by 248.8% during the 3rd quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after purchasing an additional 199 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Teleflex during the 3rd quarter worth $35,000. V Square Quantitative Management LLC purchased a new stake in shares of Teleflex during the 4th quarter worth $37,000. Finally, Cullen Frost Bankers Inc. lifted its position in shares of Teleflex by 496.7% during the 3rd quarter. Cullen Frost Bankers Inc. now owns 358 shares of the medical technology company’s stock worth $44,000 after purchasing an additional 298 shares during the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Trading Down 0.3%

NYSE TFX opened at $129.64 on Friday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55. The firm has a market cap of $5.74 billion, a PE ratio of -5.69, a P/E/G ratio of 0.97 and a beta of 0.82. Teleflex Incorporated has a one year low of $100.18 and a one year high of $139.67. The firm’s fifty day moving average is $124.46 and its two-hundred day moving average is $117.29.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. The company had revenue of $548.30 million for the quarter, compared to analyst estimates of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. Teleflex’s quarterly revenue was up 32.3% on a year-over-year basis. During the same period in the previous year, the business posted $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Analysts expect that Teleflex Incorporated will post 6.7 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th will be paid a $0.34 dividend. The ex-dividend date is Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex’s payout ratio is currently -5.96%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on TFX shares. Wells Fargo & Company lifted their price objective on shares of Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a research report on Friday, May 8th. Truist Financial reaffirmed a “hold” rating and set a $143.00 price objective (up from $135.00) on shares of Teleflex in a research report on Monday, May 11th. Bank of America raised shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price objective for the company in a research report on Monday, April 13th. Zacks Research raised shares of Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Finally, Raymond James Financial reaffirmed an “outperform” rating and set a $150.00 price objective on shares of Teleflex in a research report on Friday, May 8th. Three research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Teleflex has an average rating of “Hold” and an average target price of $144.00.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.